引用次数
引用: 2,169
H-指数: 23
I10-指数 : 36
出版物: 149
Aldo-keto reductases and cancer drug resistance
Penning , Trevor M and Jonnalagadda , Sravan and Trippier , Paul C and Ri{\v{z
Pharmacological reviews 73 ( 3) 1150 -1171
35
2021
Synthetic routes to the oxazolomycin antibiotics.
M Moloney , P Trippier , P Bulger
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 224
2002
C; Yaqoob M; Wang Z Curr
MG Moloney , P Trippier
Drug Disc. Technol 1 ( 3) 181 -199
2
2004
Cancer Drug Resistance., 2021, 73
T Penning , S Jonnalagadda , P Trippier , TL Rižner Aldo-Keto Reductases
DOI: https://doi. org/10.1124/pharmrev 120 1150 -1171
2
Synthesis of highly substituted heterocycles
P Trippier , Paul Charles Trippier
University of Oxford
2006
1: 183–198. 10.1039
Trippier PC McGuigan C MedChemComm
C0MD00119H.[CrossRef][Google Scholar]
7
2010
Strategies, Synthesis, and Successes., 2020, 63
S Kumari , A Carmona , AK Tiwari , PC Trippier Amide Bond Bioisosteres
DOI: https://doi. org/10.1021/acs. jmedchem. 0c00530. PMID: https://www. ncbi. nlm. nih. gov/pubmed/32686940 12290 -12358
3
Development of A Novel RON Targeted Antibody‐Drug Conjugates using Cysteine Bridging Technology for Potential Treatment of Pancreatic Cancer
Sreedhar Reddy Suthe , Hang‐Ping Yao , paul c trippier , ming‐hai wang
The FASEB Journal 32 807.7 -807.7
2018
SERMACS-SWRM
Kshitij Verma , Paul Trippier12
The current state of drug repurposing and rare diseases: an interview with Paul Trippier
Paul C Trippier
Future Drug Discovery 2 ( 2)
2020
Small molecule inhibitors for acute myeloid leukemia: where is the field heading?
Paul C Trippier
Future Medicinal Chemistry 9 ( 13) 1453 -1456
1
2017
Phenylboronic-acid-based carbohydrate binders as antiviral therapeutics: monophenylboronic acids
Paul C Trippier , Christopher McGuigan , Jan Balzarini
Antiviral Chemistry & Chemotherapy
2010
Back to the medicinal chemistry future
Mariateresa Giustiniano , Christian W Gruber , Caitlin N Kent , Paul C Trippier
Journal of Medicinal Chemistry 64 ( 21) 15515 -15518
1
2021
Aldo-Keto Reductase 1C3 Inhibitor Prodrug Improves Pharmacokinetic Profile and Demonstrates In Vivo Efficacy in a Prostate Cancer Xenograft Model
Krishnaiah Maddeboina , Sravan K Jonnalagadda , Ahmed Morsy , Ling Duan
Journal of Medicinal Chemistry 66 ( 14) 9894 -9915
1
2023
Discovery of an Aldo-Keto reductase 1C3 (AKR1C3) degrader
Angelica V Carmona , Shirisha Jonnalagadda , Alfie M Case , Krishnaiah Maddeboina
Communications Chemistry 7 ( 1) 95 -95
2024
Identification and characterization of two structurally related dipeptides that enhance catalytic efficiency of neurolysin
Srinidhi Jayaraman , Joanna Kocot , Shiva Hadi Esfahani , Naomi J Wangler
Journal of Pharmacology and Experimental Therapeutics 379 ( 2) 191 -202
8
2021
Functionalized Allopurinols targeting amyloid-binding alcohol dehydrogenase rescue Aβ-induced mitochondrial dysfunction
Ahmed Morsy , Krishnaiah Maddeboina , Ju Gao , Hezhen Wang
ACS Chemical Neuroscience 13 ( 14) 2176 -2190
10
2022
Excellence in Medicinal Chemistry: Celebrating ACS Medicinal Chemistry Division (MEDI) Awards. A Call for Nominations
Maria-Jesus Blanco , Amanda Bryant-Friedrich , Gunda Georg , Amjad Ali
Journal of medicinal chemistry 66 ( 11) 7067 -7069
2023
Evaluation of Urea-Based Inhibitors of the Dopamine Transporter Using the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis
Md Ashraf-Uz-Zaman , Guangchen Ji , Dalton Tidwell , Linda Yin
ACS chemical neuroscience 13 ( 2) 217 -228
3
2022
Pivotal role of nitrogen heterocycles in Alzheimer’s disease drug discovery
Shikha Kumari , Krishnaiah Maddeboina , Rinda Devi Bachu , Sai HS Boddu
Drug Discovery Today 27 ( 10) 103322 -103322
23
2022